Nachrichten zur Eagle Pharmaceuticals Aktie

Short Volatility Alert: Eagle Pharmaceuticals, Inc.

On Tuesday, shares of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) experienced volatile short activity. After the activity, the stock price went…

Form 8-K EAGLE PHARMACEUTICALS, For: Jun 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker

-- Submission seeks approval for landiolol for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial…

Eagle Pharmaceuticals to Present at the William Blair 42nd Annual Growth Stock Conference

WOODCLIFF LAKE, N.J., May 26, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) today announced that…

Form 8-K EAGLE PHARMACEUTICALS, For: May 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals to Host First Quarter 2022 Financial Results on May 9, 2022

WOODCLIFF LAKE, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX)…

Eagle Pharmaceuticals Reaches Settlement Agreement with Hospira Related to BENDEKA® (bendamustine hydrochloride) until January 17, 2028

WOODCLIFF LAKE, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”)…

Is Eagle Pharmaceuticals (EGRX) Stock Outpacing Its Medical Peers This Year?

Here is how Eagle Pharmaceuticals (EGRX) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year....…

Eagle Pharma Shares Rise 11% After It Makes Buyout Offer to Acacia Pharma

Eagle Pharma Shares Rise 11% After It Makes Buyout Offer to Acacia Pharma...…

Eagle Pharma Adds Hospital-Based Products With €95M Acacia Pharma Deal

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) has agreed to acquire Acacia Pharma Group plc read more...…

Form 8-K EAGLE PHARMACEUTICALS, For: Mar 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals to acquire U.K.-based Acacia Pharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc

WOODCLIFF LAKE, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”)…

Acacia Pharma Agrees to EUR94.7 Mln Takeover From Eagle Pharmaceuticals

Acacia Pharma Agrees to EUR94.7 Mln Takeover From Eagle Pharmaceuticals...…

Offer by Eagle Pharmaceuticals, Inc.

ACACIA PHARMA GROUP PLC...…

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals (EGRX) Q4 2021 Earnings Call Transcript

EGRX earnings call for the period ending December 31, 2021....…

Eagle Pharmaceuticals (EGRX) Lags Q4 Earnings and Revenue Estimates

Eagle Pharmaceuticals (EGRX) delivered earnings and revenue surprises of -2.30% and 10.57%, respectively, for the quarter ended December 2021. Do…

Eagle Pharmaceuticals: Q4 Earnings Insights

Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q4 earnings results on Monday, March 7, 2022 at 06:50 AM. Heres what investors need to…

Eagle Pharmaceuticals Non-GAAP EPS of $0.85 misses by $0.09, revenue of $42.32M misses by $8.76M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results

WOODCLIFF LAKE, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”)…

Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results on March 7, 2022

WOODCLIFF LAKE, N.J., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX)…

Eagle Pharmaceuticals on Track to Support Submission of NDA for Landiolol

Eagle Pharmaceuticals on Track to Support Submission of NDA for Landiolol...…

Form 8-K EAGLE PHARMACEUTICALS, For: Jan 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K EAGLE PHARMACEUTICALS, For: Jan 11

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K EAGLE PHARMACEUTICALS, For: Jan 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K EAGLE PHARMACEUTICALS, For: Dec 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharmaceuticals gets 180 days marketing exclusivity for Endo’s Vasostrict generic

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharma Receives 180 Days of Marketing Exclusivity for Vasopressin

Eagle Pharma Receives 180 Days of Marketing Exclusivity for Vasopressin...…

Form 8-K EAGLE PHARMACEUTICALS, For: Dec 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

4 High Earnings Yield Stocks Likely to Pay Off Big Time

Summit Hotel (INN), Meritage Homes (MTH), Eagle Pharmaceuticals (EGRX) and BrightSphere (BSIG) could be some attractive bets if you are…

Form 8-K EAGLE PHARMACEUTICALS, For: Dec 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K EAGLE PHARMACEUTICALS, For: Dec 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Eagle Pharma wins FDA approval for generic vasopressin

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More

Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into…